close
close

Cardlytics (CDLX) Under Investor Watch Over Growth Opportunities – Hagens Berman

Posted on by Vaseline
Cardlytics (CDLX) Under Investor Watch Over Growth Opportunities – Hagens Berman

Hagens Berman encourages CDLX investors with significant losses to contact the firm

San Francisco, California–(Newsfile Corp. – August 15, 2024) – Hagens Berman Urges Cardlytics, Inc. (NASDAQ: CDLX) investors who have suffered significant losses to file your losses now. The company also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.

Related Posts